Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CollPlant Biotechnologies (CLGN) Non-Current Assets (2017 - 2025)

Historic Non-Current Assets for CollPlant Biotechnologies (CLGN) over the last 9 years, with Q2 2025 value amounting to $4.8 million.

  • CollPlant Biotechnologies' Non-Current Assets fell 2275.72% to $4.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $4.8 million, marking a year-over-year decrease of 2275.72%. This contributed to the annual value of $5.5 million for FY2024, which is 940.37% down from last year.
  • According to the latest figures from Q2 2025, CollPlant Biotechnologies' Non-Current Assets is $4.8 million, which was down 2275.72% from $5.1 billion recorded in Q1 2025.
  • CollPlant Biotechnologies' 5-year Non-Current Assets high stood at $6137.0 billion for Q4 2021, and its period low was $4.8 million during Q2 2025.
  • Over the past 5 years, CollPlant Biotechnologies' median Non-Current Assets value was $6.5 million (recorded in 2023), while the average stood at $342.9 billion.
  • Per our database at Business Quant, CollPlant Biotechnologies' Non-Current Assets soared by 11881887386.25% in 2021 and then tumbled by 9990.04% in 2022.
  • Over the past 5 years, CollPlant Biotechnologies' Non-Current Assets (Quarter) stood at $6137.0 billion in 2021, then plummeted by 99.9% to $6.1 billion in 2022, then crashed by 99.9% to $6.1 million in 2023, then fell by 9.4% to $5.5 million in 2024, then decreased by 12.97% to $4.8 million in 2025.
  • Its Non-Current Assets was $4.8 million in Q2 2025, compared to $5.1 billion in Q1 2025 and $5.5 million in Q4 2024.